Biorithm, a Singapore-based healthtech company backed by SEEDS Capital, is looking at raising up to $8.5 million in a new funding round, according to its filings with the Accounting and Corporate Regulatory Authority (ACRA).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in